UPDATED Jun 27, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARCOMA | SEK 17.90 | 6.5% | 88.4% | SEK 236.0m | SEK 15.00 | PE25.1x | E20.5% | n/a | Healthcare | ||
HTCR | US$0.70 | -0.7% | -51.8% | US$14.2m | US$3.00 | PB3.7x | E163.1% | 11.4% | Software | ||
PNL | €1.28 | -7.6% | -18.6% | €637.0m | €1.29 | PE20.5x | E24.2% | 7.0% | Transportation | ||
FODELIA | €5.88 | 4.3% | 39.7% | €47.4m | €6.50 | PE39.4x | E28.5% | 1.4% | Food, Beverage & Tobacco | ||
CUP | AU$0.56 | 6.2% | 6.7% | AU$92.3m | AU$1.36 | PE15.8x | E40.5% | 6.8% | Commercial Services | ||
EDAC | €8.76 | -8.8% | -44.9% | €73.3m | €18.10 | PE11.7x | E27.1% | 1.7% | Capital Goods | ||
TRUE B | SEK 34.52 | -3.0% | 18.6% | SEK 11.9b | SEK 54.50 | PE21.3x | E17.6% | 1.2% | Software | ||
A119610 | ₩24,900.00 | 0% | -31.5% | ₩312.1b | ₩43,250.00 | PE27.1x | E58.4% | 2.4% | Healthcare | ||
HSAI | US$4.24 | -2.3% | -59.3% | US$554.5m | US$10.07 | PS2.2x | E71.0% | n/a | Automobiles | ||
MILDEF | SEK 66.50 | -2.9% | -0.7% | SEK 2.7b | SEK 89.00 | PE64.2x | E47.7% | 0.8% | Capital Goods | ||
4551 | NT$111.50 | -1.3% | -29.7% | NT$12.8b | NT$113.71 | PE24.3x | E31.3% | 2.2% | Automobiles | ||
EDV | CA$28.86 | -2.6% | -8.2% | CA$7.0b | CA$40.13 | PS2.4x | E46.0% | 3.8% | Materials | ||
CTH1V | €3.08 | 1.0% | 8.5% | €29.9m | €3.60 | PE19.3x | E45.6% | n/a | Capital Goods | ||
300143 | CN¥7.40 | 2.4% | -32.0% | CN¥4.7b | CN¥10.12 | PE53.9x | E28.5% | 0% | Healthcare | ||
RAY B | SEK 142.00 | 1.4% | 117.5% | SEK 4.9b | SEK 195.00 | PE48.3x | E33.6% | 0.5% | Healthcare | ||
5726 | JP¥2,795.00 | 0.3% | -3.8% | JP¥102.9b | JP¥4,450.00 | PE10.6x | E11.6% | 2.5% | Materials | ||
ARCAD | €58.00 | -4.2% | 54.2% | €5.2b | €65.36 | PE32.6x | E20.7% | 1.5% | Commercial Services | ||
LAB B | Mex$16.81 | -0.4% | 22.7% | Mex$15.9b | Mex$19.50 | PE15.2x | E28.6% | 4.7% | Pharmaceuticals & Biotech | ||
DCRU | US$0.56 | -2.6% | 20.4% | US$729.2m | n/a | PB0.8x | E104.3% | 6.4% | Real Estate | ||
ELK | NOK 20.16 | -2.6% | -17.6% | NOK 12.8b | NOK 25.60 | PB0.5x | E92.8% | 0% | Materials | ||
TCM | €2.00 | -2.0% | -43.2% | €17.2m | €5.00 | PS1.2x | E98.3% | n/a | Real Estate Management and Development | ||
A101390 | ₩6,880.00 | -0.3% | -29.4% | ₩68.5b | n/a | PB3.1x | E106.3% | n/a | Tech | ||
603236 | CN¥45.52 | -7.1% | -20.5% | CN¥11.9b | CN¥47.88 | PE42.5x | E38.9% | 0.2% | Tech | ||
603055 | CN¥10.09 | -3.3% | -5.3% | CN¥8.4b | CN¥13.43 | PE16x | E22.7% | 1.6% | Consumer Durables |